Advancing the Science

Mayo Clinic Medical Science Blog

About

January 26th, 2017

National health research treasure marks 50 years

By Elizabeth Zimmermann Young elizabethzimmermann

In 2002, Giancarlo Logroscino, M.D., Ph.D., then a research scientist at the Sergievsky Center at Columbia University in New York City, published the only paper on the long-term prognosis of status epilepticus (SE) along with research collaborators from Columbia and Mayo Clinic. They established for the first time,  in a rigorous investigation of SE in […]

View full entry · Comment on this

Tags: Dr Giancarlo Logroscino, Dr Jenny St Sauver, Dr Walter Rocca, Dr Wenjun Zhong, Mayo Clinic Alumni Magazine, population health, REP, Rochester Epidemiology Project, Science of health care delivery


January 24th, 2017

Introducing the Sepsis and Shock Response Team, and other care-improving research outcomes

By Elizabeth Zimmermann Young elizabethzimmermann

Sepsis is a potentially life-threatening complication of an infection. Typically, sepsis occurs in people who are already hospitalized, but is also diagnosed among patients who come to the emergency department. It is the most expensive condition treated in the U.S. In 2002, the Society of Critical Care Medicine and the European Society of Intensive Care […]

View full entry · Comment on this

Tags: American Journal of Medical Quality, Emergency Department, Florida, kern center, Science of health care delivery, sepsis, Sepsis and Shock Response Team, Surviving Sepsis Campaign, Dr Pablo Moreno


January 19th, 2017

Stereotactic radiosurgery is best for some brain tumors

By Elizabeth Zimmermann Young elizabethzimmermann

Shift in practice may reserve whole-brain radiation for patients with extensive disease. Patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than did patients who received SRS combined with whole-brain radiation therapy. This finding is among the results of a federally […]

View full entry · Comment on this

Tags: brain tumor, Cancer, Mayo Clinic Cancer Center, Paul D Brown, stereotactic radiosurgery


January 17th, 2017

Avoid routine double mastectomy when possible

By Elizabeth Zimmermann Young elizabethzimmermann

Consensus group urges weighing pros, cons and patient preference in unilateral breast cancer. A position paper issued by the American Society of Breast Surgeons recommends against contralateral prophylactic mastectomy (CPM) for average-risk women with breast cancer in only one breast. The recommendation on prophylactic mastectomy, published online July 28, 2016, in the Annals of Surgical […]

View full entry · Comment on this

Tags: American Society of Breast Surgeons, Breast Cancer, double mastectomy, Forefront, Judy Boughey, Mayo Clinic Cancer Center


January 12th, 2017

Health Disparities Research Retreat Focuses on Closing Gaps for Underserved

By Elizabeth Zimmermann Young elizabethzimmermann

Over 100 researchers, clinicians, educators and administrators from across Mayo Clinic, as well as outside community members, gathered in Rochester, Minnesota, for the Office of Heath Disparities Research (OHDR) Annual Retreat in October. The meeting was a platform to share science updates, learn about study support and other resources, delve into health disparities topics and collaborate […]

View full entry · Comment on this

Tags: disparities research, diversity, health disparity, NIMHD, Office of Health Disparities Research, underserved


January 10th, 2017

Meet the Investigator: Jamie N. Bakkum-Gamez, M.D.

By Elizabeth Zimmermann Young elizabethzimmermann

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Jamie N. Bakkum-Gamez, M.D., a gynecologic oncologist at Mayo Clinic in Rochester, Minnesota, discusses her research. This is one of a series of Meet the Investigator interviews […]

View full entry · Comment on this

Tags: Alan Bryce, cancer research, Forefront, Jamie Bakkum-Gamez, Joseph Mikhael, Mayo Clinic Cancer Center, Meet the Investigator, Minetta Liu, richard joseph


January 5th, 2017

Stool DNA test added to colorectal screening

By Elizabeth Zimmermann Young elizabethzimmermann

Updated guidelines make noninvasive colorectal cancer screening option available to millions.   The U.S. Preventive Services Task Force has issued its final colorectal cancer screening recommendations for 2016. The task force assigns an overall “A” grade to colorectal cancer screening in people ages 50 to 75 and fully recommends several screening exams that now include […]

View full entry · Comment on this

Tags: Cologuard, colon cancer, David Ahlquist, Forefront, US Preventive Services Task Force


December 27th, 2016

Using the Discovery-Translation-Application cycle to enhance recovery after surgery

By meghanknoedler meghanknoedler

Seventeen years is the average amount of time it takes for research to reach the patient bedside.  But this is not always the case, as a team of clinician researchers in gynecological surgery are showing. “It shouldn’t take 17 years for new discoveries to reach patients,” says Sean C. Dowdy, M.D., deputy director for practice […]

View full entry · Comment on this

Tags: discovery-translation-application, enhanced recovery after surgery, enhanced recovery pathway, ERAS, ERP, kern center, Sean C Dowdy


December 20th, 2016

New breast cancer treatment increases chances women can save their breasts

By meghanknoedler meghanknoedler

A very close family friend was just recently diagnosed with breast cancer. Even before all of her tests results came back she said, “Take both of my breasts, I don’t care.”  When someone you know or love is diagnosed with breast cancer, it’s terrifying.  All too commonly, our minds go to surgery.  This is what […]

View full entry · Comment on this

Tags: Breast Cancer, breast surgery, cancer treatment, cancer trials, clinical trials, Judy Boughey


December 15th, 2016

Combination therapy improves survival in adults with glioma

By Nicole Brudos Ferrara nicoleferrara

Radiation plus three-drug combo boosts progression-free survival and overall survival. Patients with a low-grade type of brain tumor called glioma who received radiation therapy plus a chemotherapy regimen, including procarbazine, lomustine and vincristine (PCV), experienced a longer progression-free survival and overall survival than did patients who received radiation therapy alone. These are the results of […]

View full entry · Comment on this

Tags: brain cancer, cancer reseach, glioma, Jan Buckner, lomustine, PCV, procarbazine, radiation therapy, vincristine


Contact Us · Privacy Policy